This announcement is a separate document:
嘉应制药：关于公司独立董事收到中国证监会广东监管局出具的行政监管措施决定书的公告
Jiaying Pharmaceutical: Notice on the receipt by the independent directors of the company of the administrative supervision measures decision issued by the Guangdong Regulatory Bureau of the China Securities Regulatory Commission
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.